DexCom, Inc.
General ticker "DXCM" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $30.6B (TTM average)
DexCom, Inc. follows the US Stock Market performance with the rate: 8.3%.
Estimated limits based on current volatility of 1.1%: low 63.83$, high 65.25$
Factors to consider:
- Company included in S&P500 list
- Company included in NASDAQ-100 index
- Total employees count: 10300 (+7.3%) as of 2024
- US accounted for 71.7% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Economic downturns and volatility, Pricing pressures, Public health crises, Regulatory and compliance, Supply chain disruptions
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [54.77$, 102.21$]
- 2025-12-31 to 2026-12-31 estimated range: [53.78$, 99.06$]
Financial Metrics affecting the DXCM estimates:
- Negative: with PPE of 47.6 at the end of fiscal year the price was very high
- Positive: 7.86 < Operating profit margin, % of 14.88
- Negative: negative Industry operating cash flow (median)
- Positive: Return on assets ratio (scaled to [-100,100]) of 8.16 > 6.04
- Negative: negative Industry operating income (median)
- Negative: Operating cash flow per share per price, % of 3.11 <= 6.82
- Positive: Inventory ratio change, % of -1.29 <= -0.75
Short-term DXCM quotes
Long-term DXCM plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $2,909.80MM | $3,622.30MM | $4,033.00MM |
| Operating Expenses | $2,518.60MM | $3,024.60MM | $3,433.00MM |
| Operating Income | $391.20MM | $597.70MM | $600.00MM |
| Non-Operating Income | $-0.40MM | $112.70MM | $109.00MM |
| R&D Expense | $484.20MM | $505.80MM | $552.40MM |
| Income(Loss) | $390.80MM | $710.40MM | $709.00MM |
| Taxes | $49.60MM | $168.90MM | $132.80MM |
| Profit(Loss)* | $341.20MM | $541.50MM | $576.20MM |
| Stockholders Equity | $2,131.80MM | $2,068.60MM | $2,102.60MM |
| Inventory | $306.70MM | $559.60MM | $542.60MM |
| Assets | $5,391.70MM | $6,264.50MM | $6,484.50MM |
| Operating Cash Flow | $669.50MM | $748.50MM | $989.50MM |
| Capital expenditure | $364.80MM | $236.60MM | $358.80MM |
| Investing Cash Flow | $-521.50MM | $-507.20MM | $-207.50MM |
| Financing Cash Flow | $-552.50MM | $-318.60MM | $-734.80MM |
| Earnings Per Share** | $0.88 | $1.40 | $1.42 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.